A simple, robust and complete CE-IVD validated diagnostic test of breast and ovarian related cancer for detection in MPS
The BRCA MASTR™ Dx is a molecular diagnostic assay for the identification of mutations in the coding regions of the BRCA1 and BRCA2 genes in individuals with increased risk for breast, ovarian and/or related cancers.
Multiplicom’s BRCA MASTR™ Dx is ready to use and offers robust performance with minimum hands-on time. All reagents necessary to enable multiplex amplification of 93 amplicons (289-430 bp) are included, for complete exon coverage of all coding sequences of the BRCA1 and BRCA2 genes.
The assay is compatible with all current Massively Parallel Sequencing (MPS) platforms, giving you the flexibility to choose your preferred method.